We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stable Isotope Labeling Detects Mutated Viral Strains

By LabMedica International staff writers
Posted on 31 May 2012
A bank of molecular signatures has been constructed that will help identify the severity of virus infection from characteristic changes seen in cells.

Changes in lung cells infected with swine flu from the 2009 outbreak compared with seasonal flu have been investigated using a technique called stable isotope labeling by amino acids in cell culture (SILAC) to measure and compare thousands of different proteins in a sample. More...


A team of scientists at the University of Leeds (UK) working with others from the Health Protection Agency (Porton Down, UK) used the SILAC alongside mass spectrometry to identify the proteins most affected by viral infection and used these as molecular signatures to provide the “barcode” of disease.

The study revealed how several processes in the cell were affected by the virus, with most changes seen in proteins involved in cell replication. A total of 1,427 cellular proteins were identified by two or more peptides. Studies using SILAC-based quantitative proteomics vary in the cut off value used to analyze increases and decreases in the abundance of proteins. The abundance of proteins involved in mediating antiviral responses was changed in Influenza A Virus infected cells and several integrins were decreased in abundance in virus-infected cells. Taken together, both quantitative proteomics and transcriptomic approaches can be used to identify potential cellular proteins whose functions in the virus life cycle could be targeted for chemotherapeutic intervention.

Dr John Barr, one of the senior authors, said, "Swine flu affects the lungs in a similar way to seasonal flu and this was reflected in the barcodes we found for each. Using this test might have been a way to identify how lethal the 2009 swine flu pandemic was going to be, lessening worldwide panic. Our next step is to test more lethal strains of flu, such as bird flu, to see how the barcodes differ. Flu virus frequently mutates, resulting in new strains, which may be life threatening and become pandemic. If we can test new strains using our method, we can determine their potential impact on health by comparing their barcode of disease to those of viruses already studied." The study was published on May 14, 2012, in the journal Proteomics.

Related Links:
University of Leeds
Health Protection Agency


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A new AI assistant supports treatment decisions in complex blood cancers (Image Credit: Shutterstock)

AI Decision Support System Guides Treatment Selection for Complex Blood Cancers

Treatment selection for hematologic malignancies often requires clinicians to synthesize clinical histories, genomic alterations, prior therapies, and rapidly evolving drug options. These complex decisions... Read more

Immunology

view channel
Image

Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms

Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read more

Industry

view channel
Im

Eurobio Scientific Completes Acquisition of CareDx Lab Products Division

Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.